200 related articles for article (PubMed ID: 32762861)
21. Context and Barriers to the Prescription of Nonoccupational Postexposure Prophylaxis Among HIV Medical Care Providers: National Internet-Based Observational Study in China.
Ding H; Ye Z; Tang W; Huang X; Wang H; Cui S; Jiang Y; Geng W; Xu J; Shang H
JMIR Public Health Surveill; 2021 Mar; 7(3):e24234. PubMed ID: 33704078
[TBL] [Abstract][Full Text] [Related]
22. UK guideline for the use of HIV post-exposure prophylaxis 2021.
Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
[TBL] [Abstract][Full Text] [Related]
23. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
[TBL] [Abstract][Full Text] [Related]
24. Trends of nonoccupational postexposure prophylaxis in the United States.
McCormick CD; Sullivan PS; Qato DM; Crawford SY; Schumock GT; Lee TA
AIDS; 2023 Nov; 37(14):2223-2232. PubMed ID: 37650765
[TBL] [Abstract][Full Text] [Related]
25. Pediatric Considerations for Postexposure Human Immunodeficiency Virus Prophylaxis.
Muller WJ; Chadwick EG
Infect Dis Clin North Am; 2018 Mar; 32(1):91-101. PubMed ID: 29406979
[TBL] [Abstract][Full Text] [Related]
26. HIV preexposure prophylaxis in the real world.
Daskalakis DC
Top Antivir Med; 2014; 22(4):670-5. PubMed ID: 25398067
[TBL] [Abstract][Full Text] [Related]
27. Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.
Blashill AJ; Ehlinger PP; Mayer KH; Safren SA
Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S187-90. PubMed ID: 25972502
[TBL] [Abstract][Full Text] [Related]
28. HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
DiStefano AS; Takeda M
AIDS Patient Care STDS; 2017 Feb; 31(2):60-77. PubMed ID: 28170304
[TBL] [Abstract][Full Text] [Related]
29. Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth.
Mullins TL; Zimet G; Lally M; Kahn JA
AIDS Patient Care STDS; 2016 Jul; 30(7):339-48. PubMed ID: 27410497
[TBL] [Abstract][Full Text] [Related]
30. New Canadian guideline provides evidence-based approach to non-occupational HIV prophylaxis.
O'Donnell S; Tan DHS; Hull MW
CJEM; 2019 Jan; 21(1):21-25. PubMed ID: 30457087
[TBL] [Abstract][Full Text] [Related]
31. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
[TBL] [Abstract][Full Text] [Related]
32. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men.
Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N
Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571
[TBL] [Abstract][Full Text] [Related]
33. Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.
Kalapila AG; Marrazzo J
Med Clin North Am; 2016 Jul; 100(4):927-50. PubMed ID: 27235622
[TBL] [Abstract][Full Text] [Related]
34. The Strategic Use of Antiretrovirals to Prevent HIV Infection: A Converging Agenda.
Baggaley R; Doherty M; Ball A; Ford N; Hirnschall G
Clin Infect Dis; 2015 Jun; 60 Suppl 3():S159-60. PubMed ID: 25972496
[TBL] [Abstract][Full Text] [Related]
35. Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.
Pierce AB; El-Hayek C; McCarthy D; Armishaw J; Watson K; Wilkinson A; Price B; Wright EJ; Hoy JF; Stoové MA
Sex Health; 2017 Apr; 14(2):179-187. PubMed ID: 27914484
[TBL] [Abstract][Full Text] [Related]
36. Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review.
Draughon JE; Sheridan DJ
Psychol Health Med; 2012; 17(2):235-54. PubMed ID: 22372741
[TBL] [Abstract][Full Text] [Related]
37. Overlapping HIV prevention strategies; case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men.
Smith DE; Gardiner J; Oliver R; Fagan D
Sex Transm Infect; 2017 Jun; 93(4):238-239. PubMed ID: 25795661
[TBL] [Abstract][Full Text] [Related]
38. Disparities in Awareness of HIV Postexposure and Preexposure Prophylaxis Among Notified Partners of HIV-Positive Individuals, New York City 2015-2017.
Misra K; Udeagu CC
J Acquir Immune Defic Syndr; 2017 Oct; 76(2):132-140. PubMed ID: 28902677
[TBL] [Abstract][Full Text] [Related]
39. HIV Prevention and Treatment: The Evolving Role of the Emergency Department.
Stanley K; Lora M; Merjavy S; Chang J; Arora S; Menchine M; Jacobson KR
Ann Emerg Med; 2017 Oct; 70(4):562-572.e3. PubMed ID: 28347557
[TBL] [Abstract][Full Text] [Related]
40. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
